128 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ILMN | US$140.14 | 7.2% | 48.1% | US$22.2b | US$164.60 | PS5.1x | E70.4% | 2.2% | Pharmaceuticals & Biotech | ||
APG New | US$37.01 | 3.6% | 21.8% | US$10.2b | US$43.22 | PS1.5x | E87.9% | n/a | Capital Goods | ||
LPLA | US$326.85 | 3.8% | 41.7% | US$24.5b | US$309.13 | PE24.3x | E13.5% | 0.4% | Diversified Financials | ||
GMED | US$84.72 | 3.5% | 83.9% | US$11.5b | US$90.54 | PE126.1x | E49.0% | n/a | Healthcare | ||
CIEN New | US$70.13 | 5.3% | 55.2% | US$10.1b | US$65.73 | PE73.3x | E39.5% | n/a | Tech | ||
COHR | US$105.34 | 10.5% | 190.5% | US$16.3b | US$109.50 | PS3.3x | E110.2% | n/a | Tech | ||
TWLO | US$104.35 | 8.2% | 66.0% | US$16.0b | US$84.95 | PS3.7x | E86.6% | n/a | Software | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
FND | US$112.00 | 9.3% | 21.9% | US$12.0b | US$104.04 | PE61.4x | E17.6% | n/a | Retail | ||
VRTX | US$450.97 | -3.4% | 28.8% | US$116.1b | US$514.81 | PS10.9x | E47.4% | n/a | Pharmaceuticals & Biotech | ||
RKT | US$13.74 | 2.3% | 50.2% | US$27.4b | US$15.61 | PS0.5x | E115.5% | 0% | Diversified Financials | ||
LUV | US$31.97 | -1.1% | 30.8% | US$19.2b | US$29.76 | PS0.7x | E46.2% | 2.3% | Transportation | ||
ROKU New | US$69.20 | 0.5% | -27.1% | US$10.0b | US$77.70 | PS2.6x | E60.2% | n/a | Media | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | Pharmaceuticals & Biotech | ||
DKNG | US$43.09 | 1.7% | 11.2% | US$21.0b | US$50.71 | PS4.6x | E67.3% | n/a | Consumer Services | ||
UI | US$358.48 | 6.9% | 211.8% | US$21.7b | US$310.50 | PE55.6x | E29.0% | 0.7% | Tech | ||
SNAP | US$11.42 | 8.2% | -9.9% | US$19.2b | US$13.04 | PS3.7x | E64.2% | n/a | Media | ||
MBLY | US$17.97 | 6.8% | -57.9% | US$14.6b | US$19.49 | PS8.1x | E99.6% | n/a | Automobiles | ||
LH | US$239.67 | 0.4% | 12.6% | US$20.0b | US$261.25 | PE46x | E20.6% | 1.2% | Healthcare | ||
IFF | US$90.81 | 4.8% | 21.3% | US$23.2b | US$106.20 | PS2x | E68.9% | 1.8% | Materials | ||
ALNY | US$244.89 | 5.4% | 53.8% | US$31.6b | US$301.21 | PS15.1x | E70.7% | n/a | Pharmaceuticals & Biotech | ||
COO | US$100.80 | 1.3% | 20.3% | US$20.1b | US$114.29 | PE55.9x | E23.0% | 0% | Healthcare | ||
ALB | US$108.38 | 4.2% | -10.3% | US$12.7b | US$116.41 | PS2x | E67.4% | 1.5% | Materials | ||
RKLB New | US$23.26 | 20.6% | 444.7% | US$11.6b | US$20.41 | PS32x | E52.3% | n/a | Capital Goods |